QamarJKhanMD

Clinical Trials

• Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy Start of enrollment: 2009 Mar 01

  Terminated

  Phase 2

• Vitamin D3 for Aromatase Inhibitor Induced Arthralgias Start of enrollment: 2009 Mar 01

  Completed

  Phase 2

• Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. Start of enrollment: 2009 May 01

  Completed

  Phase 2

• Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression Start of enrollment: 2009 Jul 01

  Completed

  Phase 2

• Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer Start of enrollment: 2011 Feb 01

  Unknown status

  Phase 2

• A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer Start of enrollment: 2011 Feb 01

  Completed

  Phase 1

• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01

  Completed

  Phase 2, Phase 3

• Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer Start of enrollment: 2013 Oct 22

  Active, not recruiting

  Phase 1, Phase 2

• A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer Start of enrollment: 2014 Feb 28

  Completed

  Phase 1

• Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09

  Completed

  Phase 3

• Capecitabine in Metastatic Breast and GI Cancers Start of enrollment: 2015 Oct 05

  Active, not recruiting

  Phase 2

• Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer Start of enrollment: 2016 Feb 01

  Active, not recruiting

  Phase 2

• Join now to see all